HMOX1 and myocardial infarction: While EPO treatment resulted in a further increase of HO-1 mRNA levels in concordance with previous findings in experimental models of kidney failure and myocardial infarction (17, 19), HO-1 activity, a more specific assessment for functional properties, was not further enhanced.